parkinson disease - Cleveland Clinic

Tag debug info: client: {"assets":{},"datasets":{},"live":{},"projects":{},"users":{},"observable":{"assets":{},"datasets":{},"live":{},"projects":{},"users":{}}}
Now: 1774336231205
Cache Key: cqdTagPageBySlug:parkinson-disease
fetchCache[cqdTagPageBySlug:parkinson-disease].expirationTime: falsey
fetchCache[cqdTagPageBySlug:parkinson-disease]. seconds remaining: falsey
All fetchCache expiration times:
-- Key: cqdNotFoundPage, seconds remaining: -1256932
-- Key: cqdTagPageBySlug:4c, seconds remaining: -20010434
-- Key: cqdPostsByTag:cqd-migrated-tag-21279,1,10, seconds remaining: -20010343
-- Key: cqdTagPageBySlug:michelle-medina, seconds remaining: -19196673
-- Key: cqdPostsByTag:cqd-migrated-tag-4333,1,10, seconds remaining: -19196582
-- Key: cqdTagPageBySlug:myelin, seconds remaining: -15278834
-- Key: cqdPostsByTag:cqd-migrated-tag-18309,1,10, seconds remaining: -15278737
-- Key: cqdTagPageBySlug:neuroplasticity, seconds remaining: -14345190
-- Key: cqdPostsByTag:cqd-migrated-tag-3458,1,10, seconds remaining: -14345107
-- Key: cqdTagPageBySlug:glutamyl-prolyl-trna-synthetase-eprs, seconds remaining: -12850739
-- Key: cqdPostsByTag:cqd-migrated-tag-11889,1,10, seconds remaining: -12850656
-- Key: cqdTagPageBySlug:chronic-kidney-disease, seconds remaining: -6551596
-- Key: cqdPostsByTag:cqd-migrated-tag-19979,1,10, seconds remaining: -6551505
-- Key: cqdTagPageBySlug:b-cell-lymphoma, seconds remaining: -1256932
-- Key: cqdPostsByTag:cqd-migrated-tag-24286,1,10, seconds remaining: -1256843
conditions:
-- false,
-- NA,
-- NA,
-- NA
-- false
Cache miss for key cqdTagPageBySlug:parkinson-disease - retrieving from Sanity
CCCache.dataFetchCount: 190
Cache cleanup seconds remaining: 90000

Tag: parkinson disease

Diagnosing Atypical Parkinsonian Disorders (Podcast)

New VR Platform Fuses Physical and Virtual Worlds in Parkinson’s Disease and Beyond

PET Ligand GE-180 Cleared for Testing to Assess Inflammation in Neurodegenerative Disease

Disease-Modifying Parkinson Therapy Is Put to the Test in Phase 2 Trial